Brief: Medicure Announces Settlement Of Patent Infringement Action

Medicure

21/08/2019 22:07

Aug 21 (Reuters) - Medicure Inc  MPH.V :
    * MEDICURE ANNOUNCES SETTLEMENT OF PATENT INFRINGEMENT
ACTION
    * MEDICURE INC - SETTLED ITS ONGOING PATENT INFRINGEMENT
ACTION
AGAINST GLAND PHARMA LTD
    * MEDICURE INC - GLAND HAS ACKNOWLEDGED THAT '660 PATENT IS
VALID,
ENFORCEABLE AND INFRINGED
    * MEDICURE INC - SETTLEMENT RESULTS IN COMPANY ENTERING INTO
A
LICENSE AGREEMENT WITH GLAND
    * MEDICURE INC - REMAINING TERMS OF SETTLEMENT ARE
CONFIDENTIAL
    * MEDICURE INC -  SETTLEMENT RESULTS IN ANTICIPATED LAUNCH
DATE
FOR GLAND'S GENERIC PRODUCT OF MARCH 1, 2023
    * MEDICURE INC - CO'S UNIT, MEDICURE INTERNATIONAL INC., HAS
SETTLED ONGOING PATENT INFRINGEMENT ACTION AGAINST GLAND PHARMA
LTD

Source text for Eikon:  ID:nCNWVkHg8a 
Further company coverage:  MPH.V 

 ((Reuters.Briefs@thomsonreuters.com;))